BELMONT, Calif., June 24, 2025 /PRNewswire/ -- Supercede Therapeutics, Inc., a startup biotech company focused on small molecule drug development, today announced preclinical efficacy data from its ...
CyberCube, the firm focused on cyber risk analytics, and Supercede, the global reinsurance technology platform, have announced a partnership that will make cyber reinsurance placements faster, cleaner ...
Supercede Therapeutics Inc. has released preclinical efficacy data on its small-molecule inhibitor of the Activin receptor type II (ACTRII) to treat obesity. Supercede’s lead candidate, SPCD-4-79, is ...
LONDON, August 26, 2025--(BUSINESS WIRE)--CyberCube, the market leader in cyber risk analytics, and Supercede, the global reinsurance technology platform, have announced a strategic partnership that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results